Literature DB >> 8786046

Hepatitis B virus infection in Singapore.

R Guan1.   

Abstract

Although Singapore is in an endemic region for hepatitis B infection, the hepatitis B carriage rate of 5-6% is relatively low. The highest positivity rates for hepatitis B surface antigen (HBsAg) are found in the paediatric age group, with another peak in 40-49 year olds. Studies suggest that, although perinatal transmission is an important route of infection, most children acquire the virus through horizontal transmission between family members. Viral replication continues at a high rate in young carriers and tends to slow down with increasing age. Up to 50% of hepatitis B carriers in Singapore have chronic hepatitis, shown by raised serum ALT values and liver histology, and about 10% are infected with the precore mutant virus. About 20% of carriers have cirrhosis. Among patients with HCC, up to 75% are HBsAg positive, of whom 45% are still viraemic. Mass vaccination against hepatitis B was introduced into Singapore on a voluntary basis in 1983, with compulsory vaccination of babies born to HBeAg positive mothers since 1985. The number of cases of acute hepatitis B has fallen by 60% between 1989 and 1995 although the problems of the longterm complications of chronic hepatitis B still need to be tackled.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786046      PMCID: PMC1398037          DOI: 10.1136/gut.38.suppl_2.s13

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  A preliminary survey on aflatoxin exposure in Singapore.

Authors:  R Guan; C J Oon; C Wild; R Motesano
Journal:  Ann Acad Med Singapore       Date:  1986-04       Impact factor: 2.473

2.  A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.

Authors:  A S Lok; P C Wu; C L Lai; J Y Lau; E K Leung; L S Wong; O C Ma; I J Lauder; C P Ng; H T Chung
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

3.  Vaccine-induced escape mutant of hepatitis B virus.

Authors:  W F Carman; A R Zanetti; P Karayiannis; J Waters; G Manzillo; E Tanzi; A J Zuckerman; H C Thomas
Journal:  Lancet       Date:  1990-08-11       Impact factor: 79.321

4.  Evidence of viral replication in HBsAg positive patients with hepatocellular carcinoma: measurement of serum hepatitis B virus deoxyribonucleic acid (HBV-DNA).

Authors:  R Guan; I Yap; L Wong; L H Tan; C J Oon; A Wee
Journal:  Ann Acad Med Singapore       Date:  1989-01       Impact factor: 2.473

5.  Horizontal or vertical transmission of hepatitis B virus? A serological survey in family members of hepatitis B carriers in Singapore.

Authors:  C C Tan; R Guan; I Yap; H H Tay; J Y Kang
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Sep-Oct       Impact factor: 2.184

6.  Cell-mediated immunity in patients on hemodialysis: relationship with hepatitis B carrier status.

Authors:  B W Lee; H K Yap; M Tan; R Guan; S H Quak; L Choong; B Murugasu; K T Woo; S C Jordan
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

7.  Chronic hepatitis B infection in Singapore.

Authors:  I Yap; A Wee; R Guan
Journal:  Singapore Med J       Date:  1991-10       Impact factor: 1.858

8.  Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.

Authors:  C L Lai; A S Lok; H J Lin; P C Wu; E K Yeoh; C Y Yeung
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

9.  Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal).

Authors:  P Coursaget; B Yvonnet; J Chotard; P Vincelot; M Sarr; C Diouf; J P Chiron; I Diop-Mar
Journal:  J Med Virol       Date:  1987-05       Impact factor: 2.327

10.  Hepatitis B vaccination: half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adults.

Authors:  R Guan; I Yap; H H Tay
Journal:  J Gastroenterol Hepatol       Date:  1991 Jul-Aug       Impact factor: 4.029

View more
  6 in total

1.  Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia.

Authors:  K P Ng; T L Saw; A Baki; K Rozainah; K W Pang; M Ramanathan
Journal:  Med Microbiol Immunol       Date:  2004-10-19       Impact factor: 3.402

2.  Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon.

Authors:  Márcia da Costa Castilho; Cintia Mara Costa de Oliveira; João Bosco de Lima Gimaque; Jorge Di Tommaso Leão; Wornei Silva Miranda Braga
Journal:  Am J Trop Med Hyg       Date:  2012-08-20       Impact factor: 2.345

3.  A sonographic Doppler study of the hepatic vein, portal vein and hepatic artery in liver cirrhosis: Correlation of hepatic hemodynamics with clinical Child Pugh score in Singapore.

Authors:  Azizah M Afif; Jason Pik-Eu Chang; Yan Y Wang; Simin D Lau; Fuzhen Deng; Shy Y Goh; Mar K Pwint; Chin C Ooi; Nanda Venkatanarasimha; Richard Hg Lo
Journal:  Ultrasound       Date:  2017-08-03

4.  Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours.

Authors:  W H Y Ling; P P Soe; A S L Pang; S-C Lee
Journal:  Br J Cancer       Date:  2013-05-07       Impact factor: 7.640

5.  Hepatitis B Virus Seropositivity Is a Poor Prognostic Factor of Pediatric Hepatocellular Carcinoma: a Population-Based Study in Hong Kong and Singapore.

Authors:  Anthony P Y Liu; Shui-Yen Soh; Frankie W C Cheng; Herbert H Pang; Chung-Wing Luk; Chak-Ho Li; Karin K H Ho; Edwin K W Chan; Albert C Y Chan; Patrick H Y Chung; Miriam S Kimpo; Summaiyya H Ahamed; Amos Loh; Alan K S Chiang
Journal:  Front Oncol       Date:  2020-11-20       Impact factor: 6.244

6.  Failure of sterilization in a dental outpatient facility: Investigation, risk assessment, and management.

Authors:  N Chanchareonsook; M L Ling; Q X Sim; K H Teoh; K Tan; B H Tan; K Y Fong; C Y Poon
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.